• OPEN AN ACCOUNT
Indian Indices
Nifty
26,186.45 152.70
(0.59%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,777.20 488.50
( 0.82%)
Nifty IT
38,703.65 343.40
( 0.90%)
Global Indices
Nasdaq
47,981.01 109.07
(0.23%)
Dow Jones
6,892.33 14.21
(0.21%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,667.01 -43.86
(-0.45%)
Forex
USD-INR
89.99 -0.14
(-0.16%)
EUR-INR
104.92 -0.11
(-0.11%)
GBP-INR
120.05 0.29
(0.24%)
JPY-INR
0.58 0.00
(0.11%)

EQUITY - MARKET SCREENER

Shree Ganesh Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540737
INE414Y01015
119.6214875
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
27.96
571.34
EPS(TTM)
Face Value()
Div & Yield %
15.92
10
0
 

bosch home comfort india ltd
Mphasis posts over 6% QoQ rise in Q2 PAT; clocks TCV of $528 million
Oct 31,2025

In constant currency terms, the company recorded revenue growth of 2.0% on a sequential basis.

Profit before interest, depreciation and taxes (PBIDT) for the period under review was Rs 796.26 crore, up 12.7% YoY. PBIDT margin for the second quarter of FY25 was 20.41% as against 21.00% posted in the first quarter of FY25.

Profit before tax in Q2 FY26 stood at Rs 624.78, up by 2.41% from Rs 610.07 crore in Q1 FY25.

The company recorded new TCV wins of $528 million in direct, of which 87% was in new-gen services.

Nitin Rakesh, chief executive officer and managing director, Mphasis, said: “Our early, focused investments in AI have positioned Mphasis as a strategic partner for clients navigating their transformation journey.

Another strong quarter of TCV wins of $528 million is a testimony to our AI first approach delivering business outcomes, across diverse industries.”

Mphasis is a leading Information Technology (IT) solutions provider specializing in cloud and cognitive services.

The scrip fell 2.67% to currently trade at Rs 2817.65 on the BSE.